Dexco revenue and financials
R$6.81Change from previous close: +10.37%Absolute change: +R$0.64
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 8,249 | 8,235 | 7,383 | 8,487 | — |
| Cost of revenue | 6,239 | 5,783 | 5,008 | 5,615 | — |
| Gross profit | 2,010 | 2,452 | 2,376 | 2,872 | — |
| Selling, general and administrative | 1,145 | 1,164 | 1,006 | 1,459 | — |
| Operating income | 622 | 970 | 1,247 | 1,395 | — |
| EBIT | 829 | 1,121 | 1,517 | 1,834 | — |
| EBITDA | 2,082 | 2,343 | 2,683 | 2,679 | — |
| Interest expense | 917 | 777 | 766 | 916 | — |
| Pre-tax income | -88.2 | 344 | 751 | 918 | — |
| Income tax | -151 | 170 | -60.0 | 153 | — |
| Net income | 1.2 | 172 | 790 | 756 | — |
| Net income to common shareholders | 1.2 | 172 | 790 | 756 | — |
| Basic EPS | 0.00 | 0.19 | 0.87 | 9,087.50 | — |
| Diluted EPS | 0.00 | 0.19 | 0.87 | 0.91 | — |
| Average shares (basic) | 818 | 916 | 905 | 905 | — |
| Average shares (diluted) | 820 | 916 | 908 | 905 | — |